Galectin-3 Research

2021 Translational Study: Galectin-3 in septic acute kidney injury: a translational study

2021 Preclinical Study: Galectin-3 participates in PASMC migration and proliferation by interacting with TGF-β1

2021 Translational Study: A translational study of Galectin-3 as an early biomarker and potential therapeutic target for ischemic-reperfusion induced acute kidney injury

2020 Preclinical Study: Galectin-3 Inhibition Reduces Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation

2020 Review: Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider

2020 Review: A Potential Role for Galectin-3 Inhibitors in the Treatment of COVID-19

2020 Prospective Cohort Study: Gal-3 a Potential Biomarker of Vascular Calcification for Maintenance Hemodialysis (MHD) Patients

2020 Clinical Study: Galectin-3 a Biomarker for the Early Detection of Diabetic Kidney Disease (DKD)

2020 Review and Meta-analysis: Serum Galectin-3 is Associated with Increased Risk of Atrial Fibrillation Recurrence

2020 Preclinical Study: Gal-3 Signaling Pathway is Related to Pathogenesis of Atrial Fibrillation in Diabetes

2019 Preclinical Study: Galectin-3 Blocker Targets Galectin-3-Induced STAT3 Activation to Synergize with Chemotherapy Drug Paclitaxel Against Ovarian Cancer

2019 Preclinical Study: Galectin-3 Inhibition Improves Ischemic Heart Failure by Downregulating Galectin 3 and Reducing Myocardial Fibrosis

2019 Preclinical Study: Blockade of Galectin-3 Prevents Profibrotic and Proinflammatory Effects of Cardiotrophin-1 (CT-1) in Myocardial Fibrosis

2019 Preclinical Study: Blockade of Galectin-3 Prevents Cardiac Damage, Inflammation, and Fibrosis Following Kidney Injury

2019 Preclinical Study: Galectin-3 Inhibitor Reduces the Pro-Inflammatory, Pro-fibrotic, and Pro-osteogenic Response in Aortic valves in Patients Undergoing Aortic Valve Replacement

2019 Preclinical Study: Blockade of Galectin-3 Prevents Cardiac Fibrosis, Inflammation and Functional Alterations

2018 Clinical Study: Thoughts Modulate Expression of Inflammatory Genes

2018 Preclinical Study: Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3

2018 Preclinical Study: Blockade of Galectin-3 Protects Against Renal Injury and Fibrosis

2018 Preclinical Study: Inhibition of Galectin-3 Mitigates Diet-Induced Cardiac Lipotoxicity and Reduces Mitochondrial Damage

2018 Preclinical Study: Inhibition of Galectin-3 Reduces Inflammatory Mediators and Decreases Kidney Damage in Spontaneous Hypertension Model

2017 Review: Galectin-3—A Key Player in Arthritis

2017 Preclinical Study: Galectin-3 Blockade Protects Vascular Tissue against Abdominal Aortic Aneurism

2017 Preclinical Study: Galectin-3 Blockade Prevents Cardiac Remodeling, Fibrosis and Inflammation Associated with Early Aortic Stenosis

2017 Preclinical Study: Galectin-3 Inhibition Reduces Size of Atherosclerotic Lesions

2017 Preclinical Study: Galectin-3 inhibition Blocks Inflammation, Fibrosis and Calcification in Aortic Valves

2016 Preclinical Study: Galectin-3 Blockade Reduces Renal Fibrosis, Inflammation and Damage

2016 Preclinical Study: Inhibition of Galectin-3 Prevents Adipose Tissue Remodeling in Obesity

2016 Preclinical Study: Galectin-3 Blockade Suppresses Neuropathic Pain and Decreases Proinflammatory Mediators Following Peripheral Nerve Injury

2015 Preclinical Study: Inhibition of Galectin-3 Prevents Obesity-Related Cardiovascular Remodeling

2013 Preclinical Study: Galectin-3 Blockade Reverses Vascular Hypertrophy and Fibrosis

2013 Preclinical Study: Modified Citrus Pectin Reverses Vascular Hypertrophy and Fibrosis, via Inhibition of Galectin-3

2012 American Heart Association Study: Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

2012 Review: Circulating Galectin-3 in the Bloodstream: An Emerging Promoter of Cancer Metastasis

2011 Preclinical Study: Galectin 3 Aggravates Joint Inflammation and Destruction in Antigen-Induced Arthritis.

2011 Preclinical Study: Galectin-3 Blockade Reduces Kidney Disease Severity

Additional Galectin-3 Research Areas

Read More:  Galectin-3 in Arthritis & Inflammation

Read More: Galectin-3 in Bladder Cancer

Read More: Galectin-3 in Breast Cancer

Read More:  Galectin-3 in Prostate Cancer

Read More: Galectin-3 in Cancer Metastasis

Read More:  Cardiovascular/Circulatory System

Read More:  Galectin Structural/Binding/Function

Read More:  Galectin-3 and Gastrointestinal

Read More: Galectin-3 in Immunity & Autoimmunity

Read More:  Galectin-3 in Kidney

Read More:  Galectin-3 in Liver

Read More:  Galectin-3 in Lungs

Read More:  Galectin-3 Parasites

Read More: Galectin-3 in Diabetes

Read More:  Galectin-3 in Skin

0
Your Cart
Your cart is empty
Payment plan details

Payment plan consists of 3 installments and includes a $300 upcharge per registrant. The 1st installment is due upon purchase, the 2nd installment will be charged automatically to the card on file 30 days from initial payment and the 3rd installment will be changed 60 days from initial payment.

Payment Plan is available through June 1st.

Please note that the payment plan option is only available for the retreat itself. Any add-ons will be due along with the initial retreat payment and registration.

Payment Plan Breakdown

SINGLE OCCUPANCY
Three installments of $1765 each

DOUBLE OCCUPANCY
Three installments of $2996 each ($1498 per registrant)

RATES & FEES
Extended Daily Rate for Add-On Dates to Retreat

* Daily rate is exclusive of taxes and resort experience fee.

Applicable to these dates only (supplies are limited)

Sunday, September 15th SOLD OUT
Monday, September 16th
Saturday, September 21st
Sunday, September 22nd SOLD OUT

Daily Rate: $499*

Total Rate: $645.23
Room G.E.T. Tax 4.71% / Room T.A.T. Tax 13.25%

Fees Details
The daily resort experience fee of $48 plus tax includes self-parking, internet access, wellness & cultural classes, shuttle bus service, lei greeting, 1 branded reusable water bottle per registered guest, snorkle rental (one hour/day), and local & domestic long distance calls.

Is your body's survival response working against you?

Download book excerpt

By submitting this form you are agreeing to receive email communications from Dr. Eliaz